Introduction
Every patient is unique — so why should medication be one-size-fits-all? The science of pharmacogenomics recognizes that genetic differences between individuals can significantly affect how they respond to medications.
At PillarsDx, we offer advanced pharmacogenomic testing, also known as PGx testing, that helps healthcare providers make smarter, safer, and more personalized prescribing decisions.
By identifying how a patient’s genetic profile may influence drug response, PGx testing supports the future of precision medicine — helping providers choose the right medication and the right dose with greater confidence.
What Is Pharmacogenomics?
Pharmacogenomics, or PGx, is the study of how a person’s genes influence their response to medications. Genetic variations can affect how quickly or slowly the body metabolizes a drug, whether the medication will be effective, and how likely a patient is to experience side effects.
For example, a patient who is a poor metabolizer of a particular drug may accumulate dangerously high levels of that medication in their system, even when taking a standard dose. On the other hand, an ultra-rapid metabolizer may process the drug so quickly that it provides little to no therapeutic benefit.
PGx testing takes the guesswork out of prescribing by giving providers the genetic context they need to choose the right drug and the right dose from the start. PillarsDx is proud to offer this advanced testing capability as part of our commitment to precision medicine and patient-centered care.
How PGx Testing Works
Pharmacogenomic testing is simple, non-invasive, and easy to integrate into a clinical workflow. At PillarsDx, the process generally involves a quick sample collection followed by laboratory analysis and a comprehensive provider report.
The PGx testing process includes:
- A cheek swab or saliva sample collected from the patient
- The sample is analyzed in our certified laboratory
- A comprehensive PGx report is generated, identifying genetic variants relevant to drug metabolism
- The report is returned to the provider, typically within 24–48 hours
The results help identify how a patient is likely to respond to hundreds of commonly prescribed medications across a wide range of therapeutic areas, including psychiatry, cardiology, pain management, oncology, and more.
Which Genes Does PGx Testing Analyze?
PGx testing focuses on genes that encode drug-metabolizing enzymes. These enzymes play a major role in how medications are processed, activated, or cleared from the body.
Some of the most commonly analyzed genes include:
- CYP2D6 — Affects metabolism of antidepressants, antipsychotics, opioids, and beta-blockers.
- CYP2C19 — Relevant to antidepressants, antifungals, and proton pump inhibitors.
- CYP2C9 — Impacts metabolism of NSAIDs, warfarin, and certain diabetes medications.
- CYP3A4/CYP3A5 — Among the most important liver enzymes involved in metabolizing a wide variety of drugs.
- TPMT and DPYD — Important for safe dosing of certain chemotherapy agents.
At PillarsDx, our comprehensive PGx panels cover the genetic variants most relevant to clinical decision-making, giving providers actionable insights that can be directly applied to the patient’s care plan.
Who Benefits From PGx Testing?
PGx testing is valuable across a broad spectrum of clinical settings. It is especially useful for patients who take multiple medications, have a history of medication side effects, or have not responded well to standard treatment options.
Psychiatry and Behavioral Health — Finding the right psychiatric medication can take months of trial and error. PGx testing provides insight into how a patient may metabolize antidepressants, antipsychotics, and anti-anxiety medications, helping reduce the guesswork in treatment planning.
Pain Management — Genetic variation in opioid metabolism can mean the difference between effective pain relief and dangerous toxicity. PGx testing helps pain management providers make safer, more effective prescribing decisions.
Cardiology — Medications such as warfarin and clopidogrel, also known as Plavix, have narrow therapeutic windows and can be significantly affected by genetic variation. PGx results allow providers to make more precise medication decisions.
Primary Care — For patients on multiple medications, PGx testing can help identify potential drug-gene interactions and reduce the risk of adverse drug events.
PillarsDx supports healthcare providers with advanced testing services designed to improve prescribing confidence, patient safety, and treatment outcomes.
The Real-World Impact of PGx Testing
The case for pharmacogenomic testing is backed by a growing body of clinical evidence. Medication response varies widely between patients, and genetics can play a major role in that variation.
PGx testing may help providers:
- Reduce medication trial-and-error
- Lower the risk of adverse drug reactions
- Improve medication selection and dosing decisions
- Support better outcomes in patients taking psychiatric, cardiac, pain, or oncology medications
- Personalize treatment based on the individual patient, not just the diagnosis
When providers use PillarsDx PGx results to guide prescribing, they are not just treating the diagnosis — they are treating the individual. This shift from population-based medicine to personalized medicine is one of the most important trends in modern healthcare, and PillarsDx is proud to support that progress.
PGx Testing and Medication Compliance
There is another often-overlooked benefit of PGx testing: improved medication compliance. When patients understand that their medication has been selected with their genetic profile in mind, they may feel more confident and engaged in their treatment plan.
This is especially important in conditions such as depression, schizophrenia, chronic pain, and other long-term health concerns where medication adherence can be a significant challenge.
PGx testing gives providers another tool to educate patients, explain treatment choices, and build trust in the care plan. When patients understand the “why” behind a medication, they are often more likely to follow through consistently.
Fast Turnaround and Concierge Service
At PillarsDx, we know that clinical decisions cannot wait. Our PGx results are delivered with the same priority processing and fast turnaround that defines our approach to diagnostic testing.
With same-day courier pickup, dedicated account management, and fast 24–48 hour turnaround times, PillarsDx gives providers the answers they need when they need them.
Our concierge approach means no call centers, no unnecessary delays, and no confusion. Just clear, actionable results delivered by a team that understands the real demands of clinical practice.
Get Started With PGx Testing at PillarsDx
Personalized medicine is no longer just a vision of the future — it is here, and it is available to your patients right now through PillarsDx.
Our pharmacogenomic testing program is designed to integrate seamlessly into your practice, with minimal workflow disruption and maximum clinical value. Whether you are managing psychiatric medications, pain therapies, cardiac medications, or complex medication regimens, PGx testing can help support safer and more personalized care.
Contact us today at 404-777-1551 or email [info@labservicesofga.com](mailto:info@labservicesofga.com) to speak with our team about adding PGx testing to your practice.
You can also visit our contact page or explore our full list of services to see everything PillarsDx has to offer.
